Analyst Ratings for Clovis Oncology (CLVS)

CLVS Rating Summary

  |   Expand Research on CLVS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.9 / 10   Percentile Rank: 38%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/10/2022 JPMorgan Brian Cheng Downgrade Underweight
(Neutral)		 N/A
(N/A)		 0.98
(0.08)		 -91.84% Details
4/27/2020 Leerink Partners Andrew Berens Downgrade Underperform
(Market Perform)		 5.00
(N/A)		 9.03
(0.08)		 -99.11% Details